OWA
IMMU

One Wealth Advisors’s Immunomedics Inc IMMU Stock Holding History

One Wealth Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-74
Closed -$1K – 550
2019
Q1 		$1K Buy
+74
New +$1.19K ﹤0.01% 557
2018
Q4 		– Sell
-74
Closed -$2K – 546
2018
Q3 		$2K Hold
74
– – ﹤0.01% 531
2018
Q2 		$2K Buy
+74
New +$1.49K ﹤0.01% 525

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

One Wealth Advisors's IMMU Position: Q2 2019 in Review

One Wealth Advisors sold out of Immunomedics Inc (IMMU) in Q2 2019, closing a stake of 74 shares — an estimated $1K sold.

One Wealth Advisors first reported a position in IMMU in Q2 2018 and held it in 3 quarters. The position peaked at $2K in Q3 2018. 204 funds tracked by Wall St. Rank hold IMMU as of Q2 2019.

  • One Wealth Advisors reported no remaining Immunomedics Inc position as of Q2 2019 after selling out during the quarter.
  • One Wealth Advisors sold 74 Immunomedics Inc shares in Q2 2019, an estimated $1K.
  • One Wealth Advisors first reported a position in Immunomedics Inc in Q2 2018 and held it in 3 quarters.
  • One Wealth Advisors's Immunomedics Inc position peaked at $2K in Q3 2018.
  • 204 funds tracked by Wall St. Rank held Immunomedics Inc as of Q2 2019.

Based on One Wealth Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.